Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

被引:0
|
作者
Pankaj Puar
Makoto Hibino
C. David Mazer
Andrew T. Yan
Arjun K. Pandey
Adrian Quan
Hwee Teoh
David A. Hess
Raj Verma
Kim A. Connelly
Subodh Verma
机构
[1] St. Michael’s Hospital of Unity Health Toronto,Division of Cardiac Surgery
[2] Keenan Research Centre for Biomedical Science in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital,Department of Pharmacology and Toxicology
[3] University of Toronto,Faculty of Medicine
[4] University of British Columbia,Department of Cardiac Surgery
[5] University Hospitals Cleveland Medical Center,Department of Anesthesia
[6] Case Western Reserve University,Departments of Anesthesiology and Pain Medicine
[7] St. Michael’s Hospital of Unity Health Toronto,Department of Physiology
[8] University of Toronto,Division of Cardiology
[9] University of Toronto,Department of Medicine
[10] St. Michael’s Hospital of Unity Health Toronto,Michael G. DeGroote School of Medicine
[11] University of Toronto,Division of Endocrinology and Metabolism
[12] McMaster University,Molecular Medicine Research Laboratories, Krembil Centre for Stem Cells Biology, Robarts Research Institute
[13] St. Michael’s Hospital of Unity Health Toronto,Department of Physiology and Pharmacology
[14] University of Western Ontario,Department of Surgery
[15] University of Western Ontario,undefined
[16] Royal College of Surgeons in Ireland,undefined
[17] University of Toronto,undefined
来源
关键词
SGLT2 inhibition; Diabetes; Heart failure; Cardiac reverse remodelling; Left ventricle;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy
    Porciani, Maria Cristina
    Lilli, Alessio
    Macioce, Roberto
    Cappelli, Francesco
    Demarchi, Gabriele
    Pappone, Alessia
    Ricciardi, Giuseppe
    Padeletti, Luigi
    EUROPEAN HEART JOURNAL, 2006, 27 (15) : 1818 - 1823
  • [42] Left Ventricular Mass-To-Strain Ratio Predicts Cardiac Amyloid Subtype
    Geenty, Paul
    Sivapathan, Shantosh
    Stefani, Luke D.
    Boyd, Anita
    Richards, David
    Kwok, Fiona
    Taylor, Mark S.
    Stewart, Graeme
    Thomas, Liza
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (03) : 690 - 692
  • [43] Left Ventricular Mass Predicts Response to Cardiac Resynchronization Therapy in Men but Not Women
    Ward, Chad C.
    Ayinde, Hakeem
    Adams, Casey
    Adeola, Oluwaseun
    Zubairu, Josiah
    Dezorzi, Christopher
    Hopson, James
    Sigurdsson, Gardar
    Giudici, Michael
    CIRCULATION, 2018, 138
  • [44] Predictors of left ventricular reverse remodelling in cardiac resynchronization therapy at multivariate analysis: important role of etiology
    Boriani, G.
    Diemberger, I.
    Biffi, M.
    Martignani, C.
    Cervi, E.
    Valzania, C.
    Bertini, M.
    Saporito, D.
    Ziacchi, M.
    Branzi, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 16 - 16
  • [45] Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy
    de Veire, N. R. Van
    Yu, C-M
    Ajmone-Marsan, N.
    Bleeker, G. B.
    Ypenburg, C.
    De Sutter, J.
    Zhang, Q.
    Fung, J. W. H.
    Chan, J. Y. S.
    Holman, E. R.
    van der Wall, E. E.
    Schalij, M. J.
    Bax, J. J.
    HEART, 2008, 94 (03) : e9
  • [46] Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure
    Francia, Pietro
    Balla, Cristina
    Ricotta, Agnese
    Uccellini, Arianna
    Frattari, Alessandra
    Modestino, Anna
    Borro, Marina
    Simmaco, Maurizio
    Salvati, Adriano
    De Biase, Luciano
    Volpe, Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (03) : 306 - 310
  • [47] IMPACT OF DIABETES DURATION ON LEFT VENTRICULAR MASS REGRESSION WITH EMPAGLIFLOZIN
    Moroney, Michael
    Verma, Raj
    Hibino, Makoto
    Mazer, C. David
    Connelly, Kim
    Yan, Andrew T.
    Quan, Adrian
    Teoh, Hwee
    Verma, Subodh
    Puar, Pankaj
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 289 - 289
  • [48] Impact of diabetes duration on left ventricular mass regression with empagliflozin
    Moroney, Michael
    Verma, Raj
    Hibino, Makoto
    Mazer, C. David
    Connelly, Kim A.
    Yan, Andrew T.
    Quan, Adrian
    Teoh, Hwee
    Verma, Subodh
    Puar, Pankaj
    ESC HEART FAILURE, 2023, 10 (03): : 2134 - 2140
  • [49] Early cardiac reverse remodelling in a large cohort of patients with HFrEF treated with sacubitril/valsartan
    Mapelli, Massimo
    Salvioni, Elisabetta
    Mattavelli, Irene
    Sassi, Valentina
    Mantegazza, Valentina
    Volpato, Valentina
    Vignati, Carlo
    De Martino, Fabiana
    Paolillo, Stefania
    Fusini, Laura
    Muratori, Manuela
    Pepi, Mauro
    Agostoni, Piergiuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J132 - J133
  • [50] Myocardial contractile reserve predicts left ventricular reverse remodeling and cardiac events in dilated cardiomyopathy
    Morimoto, Ryota
    Okumura, Takahiro
    Hirashiki, Akihiro
    Ishii, Hideki
    Ichii, Takeo
    Aoki, Soichiro
    Furusawa, Kenji
    Hiraiwa, Hiroaki
    Kondo, Toru
    Watanabe, Naoki
    Kano, Naoaki
    Fukaya, Kenji
    Sawamura, Akinori
    Takeshita, Kyosuke
    Bando, Yasuko K.
    Murohara, Toyoaki
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 303 - 309